Log in to save to my catalogue

Impact of the 2013 ASCO/CAP HER2 Guideline Updates at an Academic Medical Center That Performs Prima...

Impact of the 2013 ASCO/CAP HER2 Guideline Updates at an Academic Medical Center That Performs Prima...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1697214961

Impact of the 2013 ASCO/CAP HER2 Guideline Updates at an Academic Medical Center That Performs Primary HER2 FISH Testing: Increase in Equivocal Results and Utility of Reflex Immunohistochemistry

About this item

Full title

Impact of the 2013 ASCO/CAP HER2 Guideline Updates at an Academic Medical Center That Performs Primary HER2 FISH Testing: Increase in Equivocal Results and Utility of Reflex Immunohistochemistry

Publisher

England

Journal title

American journal of clinical pathology, 2015-08, Vol.144 (2), p.247-252

Language

English

Formats

Publication information

Publisher

England

More information

Scope and Contents

Contents

The 2013 American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guideline updates lowered the threshold for HER2 positivity and altered the equivocal category. The goal of this study was to evaluate the impact of these changes on the distribution of HER2 fluorescence in situ hybridization (FISH) status. The utility of r...

Alternative Titles

Full title

Impact of the 2013 ASCO/CAP HER2 Guideline Updates at an Academic Medical Center That Performs Primary HER2 FISH Testing: Increase in Equivocal Results and Utility of Reflex Immunohistochemistry

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1697214961

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1697214961

Other Identifiers

E-ISSN

1943-7722

DOI

10.1309/AJCPE5NCHWPSMR5D

How to access this item